The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is urging the U.S. Congress to pass H.R. 6948, which would keep the pass-through status for diagnostic radiopharmaceuticals under Medicare reimbursement.

Appeals for payment denials were overturned 75 percent of the time by Medicare Advantage Organizations from 2014 to 2016, according to HHS Office of Inspector General.

Despite growing support for a Medicare for All system among Democrats, HHS Secretary Alex Azar blasted such an idea during a speech in Tennessee this week, The Hill reported.

The World Molecular Imaging Society (WMIS) awarded its highest honor, the 2018 Gold Medal Award, to Robert J. Gillies, PhD, for his “renowned dedication to the molecular imaging community and revolutionary contributions to the field.”

New research published in the Journal of Nuclear Medicine suggests a 18F-FDG PET/CT scan reveals previously undetected breast cancers in male patients with pre-PET/CT stage IIB breast cancer, and in patients with stage III breast cancer.

When UC San Diego Health introduced its expanded Comprehensive Breast Health Center this spring, Haydee Ojeda-Fournier, MD, medical director of breast imaging, got right to the point for the press covering the development. She emphasized that the informal reopening had doubled the capacity of an existing program and that the center now houses an integrated suite of numerous advanced-imaging technologies all under one roof.

Second opinions from a multi-disciplinary tumor board (MTB) at a National Cancer Institute (NCI)-designated cancer center changed the diagnosis of 43 percent of breast cancer patients, according to a new study published in the Annals of Surgical Oncology.

The U.S. Department of Health and Human Services did not violate certain legal provisions when it reduced public outreach to alert people to healthcare enrollment periods and put out social media posts that blasted Obamacare, according to the Government Accountability Office.